title: Lipid biomarkers and cardiovascular risk: which path to take at the fork in the road?
authors.affiliation: South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address: stephen.nicholls@sahmri.com.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Nicholls
authors.affiliation: Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Sydney, Australia.
authors.forename: Leonard
authors.initials: L
authors.lastname: Kritharides
mesh_terms: D053299:Apolipoprotein B-100 / Q000378:metabolism*; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000209:etiology*; D003327:Coronary Disease / Q000188:drug therapy*; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010743:Phospholipids / Q000378:metabolism*; D011758:Pyrroles / Q000008:administration & dosage*
chemical_list: D053299:Apolipoprotein B-100; D006538:Heptanoic Acids; D010743:Phospholipids; D011758:Pyrroles; D000069059:Atorvastatin
keywords: atherosclerosis; inflammation; oxidation; risk factor; statin